Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 2

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

otilimab (GSK3196165) / GSK

NCT01023256 / 2007-006129-29: Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis

	P1b/2a trial in RA at EULAR 2015
	Jun 2015 - Jun 2015: P1b/2a trial in RA at EULAR 2015
	Rheumatoid arthritis
	Feb 2014 - Feb 2014: Rheumatoid arthritis
	For rheumatoid arthritis
	May 2013 - May 2013: For rheumatoid arthritis
	P1/2 data: ACR LBA (RA)
	Nov 2012 - Nov 2012: P1/2 data: ACR LBA (RA)
	P1b/P2a data (RA)
	Sep 2012 - Sep 2012: P1b/P2a data (RA)
More

Completed

1/2

Europe, RoW

MOR103

MorphoSys AG

Rheumatoid Arthritis

06/12

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites